Clinical Trials Directory

Trials / Completed

CompletedNCT01961050

Preventing FAS/ARND in Russian Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
767 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate an intervention aimed at reducing risk for alcohol-exposed pregnancies and preventing Fetal Alcohol Spectrum Disorders in Russian children. The study will determine whether physicians, trained in a dual-focused brief motivational intervention and monitored for performance, can foster greater change in knowledge, health beliefs, alcohol use, and alcohol-exposed pregnancy risk in Russian women who are at risk than standard care.

Detailed description

The study is a two-arm, 20-site, site-randomized, controlled trial testing an intervention to reduce risk for alcohol-exposed pregnancies in at-risk women (at-risk drinking childbearing age women who are heterosexually active, and not consistently using contraception). The trial will assess feasibility of a dual-focused (i.e. contraception use-drinking reduction) brief physician intervention (DFBPI) and determine whether physicians, trained in DFBPI and monitored for compliance, can foster greater reduction of women's risk behaviors compared to standard care. The intervention is specifically designed to be deliverable routinely by Obstetrics and Gynecology physicians(OB/GYN) to large numbers of women at women's clinics.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDual-Focused Brief Physician Intervention (DFBPI)The DFBPI is incorporated in OB/GYN clinic visit. The intervention consists of two brief (5 to 10 minutes) manualized counseling segments delivered face-to-face by an OB/GYN in the context of two clinic visits.
OTHERServices as usualActive Comparator: Standard OB/GYN clinic visits that include OB/GYN services as usual.

Timeline

Start date
2007-09-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2013-10-11
Last updated
2016-02-19

Locations

2 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT01961050. Inclusion in this directory is not an endorsement.